The discovery grant program encourages new basic research focused on identifying causes of or treatments for ALS. The goal of this program is to build a foundation of data for novel, out-of-the-box ideas in ALS research or to attract investigators from related fields who bring new expertise to ALS research.
ALS Canada partners with Brain Canada (with the financial support of Health Canada) on this program in order to leverage contributions made through the Ice Bucket Challenge.
Status:
Partners:
Ensuring that Canada continues to have a strong community of talented ALS researchers is the goal of this research funding, which supports senior postdoctoral trainees as well as recently hired junior faculty members to secure or maintain a faculty job in Canada.
Recipients of this funding are all pursuing forward thinking, high-impact ALS research aimed squarely at helping to make the disease treatable, not terminal. Furthermore, this research will have a broader impact on our understanding of other neurodegenerative diseases.
Status:
Partners:
This program supports specialized training in clinical care and research skills related to ALS. The program awards a researcher $100,000 per year for two years and is designed to strengthen the Canadian ALS clinical community. Peer review is performed by a panel of not-in-conflict Canadian ALS clinicians.
Status:
Partners:
By providing salary support to PhD students, trainees with a postdoctoral position, or clinical fellows or recently-hired junior faculty members, these grants attract the brightest young minds to ALS research, bringing new ideas to the field and maintaining Canadian ALS research excellence into the future. The Trainee Grant category represents a combination of different grant programs prior to 2017.
Status:
Partners:
Named after Dr. Arthur J. Hudson, the co-founder of ALS Canada, this grant program brings together researchers from across the country to accelerate therapeutic development by: 1) identifying and testing a relevant therapeutic target or candidate therapy and/or 2) addressing critical needs for early diagnosis and biomonitoring of clinical progression applied to clinical research.
Research in all stages of development is welcomed, from basic/preclinical to Phase l, II and Ill clinical trials. ALS Canada partners with Brain Canada (with the financial support of Health Canada) on this program in order to leverage contributions made through the Ice Bucket Challenge.
Status:
Partners:
Project Grants provide funding for three different types of ALS research:
The Project Grant category represents a combination of three different grant programs prior to 2017.
Status:
Partners:
We will continue to fund the most promising ALS research in Canada to advance treatment discoveries and shed light on the complex genetic, biological and environmental factors involved in ALS.
We use cookies and other technologies to understand how you use our site and to improve your experience and provide you with valuable content. By continuing on this website, you consent to the use of these cookies. For more information and to opt-out of cookies, visit the cookie section of our privacy policy.